Cannabinoid type 1 receptors located on single-minded 1-expressing neurons control emotional behaviors

Neuroscience

Volumn 204, Issue , 2012, Pages 230-244

  Dubreucq, S ^a,b   Kambire, S ^a,b   Conforzi, M ^a,b   Metna Laurent, M ^a,b   Cannich, A ^a,b   Soria Gomez, E ^a,b   Richard, E ^a,b   Marsicano, G ^a,b   Chaouloff, F ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anxiety; CB1 receptor; Conditioned fear; Locomotor reactivity; Single minded 1; Social defeat stress

Indexed keywords

CANNABINOID 1 RECEPTOR; CRE RECOMBINASE; GENOMIC DNA; MESSENGER RNA;

ACUTE STRESS; ALLELE; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BASAL AMYGDALA; BEHAVIOR CONTROL; BODY WEIGHT; BRAIN STEM; CANNABINOID TYPE 1 RECEPTOR GENE; CONDITIONED REFLEX; CONTROLLED STUDY; EMOTIONALITY; FLUID INTAKE; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD INTAKE; GENE; GENE EXPRESSION REGULATION; INHIBITION (PSYCHOLOGY); LOXP SITE; MALE; MAZE TEST; MOTOR CONTROL; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PARAVENTRICULAR THALAMIC NUCLEUS; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINGLE MINDED 1 GENE; SOCIAL STRESS; STIMULUS RESPONSE; SUGAR INTAKE; SUPRAOPTIC NUCLEUS;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING (PSYCHOLOGY); EMOTIONS; FEAR; MALE; MEMORY; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURONS; RECEPTOR, CANNABINOID, CB1; REPRESSOR PROTEINS;

EID: 84857125716     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.049     Document Type: Article

References (70)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 2002, 68:247-286.
2. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 1973, 21:205-235.
3. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., Ferreira M., Tang V., McGovern R.A., Kenny C.D., Christiansen L.M., Edelstein E., Choi B., Boss O., Aschkenasi C., Zhang C.Y., Mountjoy K., Kishi T., Elmquist J.K., Lowell B.B. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123:493-505.
4. Bellocchio L., Lafenêtre P., Cannich A., Cota D., Puente N., Grandes P., Chaouloff F., Piazza P.V., Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 2010, 13:281-283.
5. Berton O., Aguerre S., Sarrieau A., Mormède P., Chaouloff F. Differential effects of social stress on central serotonergic activity and emotional reactivity in Lewis and spontaneously hypertensive rats. Neuroscience 1998, 82:147-159.
6. Berton O., Durand M., Aguerre S., Mormède P., Chaouloff F. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain. Neuroscience 1999, 92:327-341.
7. Buwalda B., Kole M.H.P., Veenema A.H., Huininga M., de Boer S.F., Korte S.M., Koolhaas J.M. Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning. Neurosci Biobehav Rev 2005, 29:83-97.
8. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76.
9. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grübler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148:1574-1581.
10. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
11. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Neurosci 2005, 4:775-790.
12. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003, 23:4850-4857.
13. Duplan S.M., Boucher F., Alexandrov L., Michaud J.L. Impact of Sim1 gene dosage on the development of the paraventricular and supraoptic nuclei of the hypothalamus. Eur J Neurosci 2009, 30:2239-2249.
14. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
15. Fan C.M., Kuwana E., Bulfone A., Fletcher C.F., Copeland N.G., Jenkins N.A., Crews S., Martinez S., Puelles L., Rubenstein J.L.R., Tessier-Lavigne M. Expression patterns of two murine homologs of drosophila single-minded suggest possible roles in embryonic patterning and in the pathogenesis of Down syndrome. Mol Cell Neurosci 1996, 7:11-16.
16. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 2001, 125:151-157.
17. Fyffe S.L., Neul J.L., Samaco R.C., Chao H.T., Ben-Shachar S., Moretti P., McGill B.E., Goulding E.H., Sullivan E., Tecott L.H., Zoghbi H.Y. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 2008, 59:947-958.
18. Glass M., Dragunow M., Faull R. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal neonatal and adult human brain. Neuroscience 1997, 77:299-331.
19. Gozzi A., Jain A., Giovanelli A., Bertolini C., Crestan V., Schwarz A.J., Tsetsenis T., Ragozzino D., Gross C.T., Bifone A. A neural switch for active and passive fear. Neuron 2010, 67:656-666.
20. Guimarães F.S., Beijamini V., Moreira F.A., Aguiar D.C., de Lucca A.C.B. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 2005, 29:1313-1322.
21. Haller J., Varga B., Ledent C., Barna I., Freund T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004, 19:1906-1912.
22. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 1990, 87:1932-1936.
23. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 2010, 30:14980-14986.
24. Houchi H., Babovic D., Pierrefiche O., Ledent C., Daoust M., Naassila M. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 2005, 30:339-349.
25. Huhman K.L. Social conflict models: can they inform us about human psychopathology?. Horm Behav 2006, 50:640-646.
26. Jacob W., Yassouridis A., Marsicano G., Monory K., Lutz B., Wotjak C.T. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav 2009, 8:685-698.
27. Kamprath K., Romo-Parra H., Häring M., Gaburro S., Doengi M., Lutz B., Pape H.C. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 2011, 36:652-663.
28. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001, 21:9506-9518.
29. Katona I., Sperlágh B., Ski A., Käfalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999, 19:4544-4558.
30. Koolhaas J.M., Korte S.M., De Boer S.F., Van der Vegt B.J., Van Reenen C.G., hopster H., De Jong I.C., Ruis M.A.W., Blokhuis H.J. Coping styles in animals: current status in behavior and stress-physiology. Neurosci Biobehav Rev 1999, 23:925-935.
31. Lafenêtre P., Chaouloff F., Marsicano G. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol Res 2007, 56:367-381.
32. Lafenêtre P., Chaouloff F., Marsicano G. Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system. Neuropharmacology 2009, 57:715-721.
33. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.-F., Beslot F., Böhme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
34. Leigh Gibson E. Emotional influences on food choice: sensory, physiological and psychological pathways. Physiol Behav 2006, 89:53-61.
35. Li C.I., Maglinao T.L., Takahashi L.K. Medial amygdala modulation of predator odor-induced unconditioned fear in the rat. Behav Neurosci 2004, 118:324-332.
36. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacol Ther 1990, 46:321-340.
37. Lutz B. Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 2009, 9:46-52.
38. Maren S., Quirk G.J. Neuronal signalling of fear memory. Nat Rev Neurosci 2004, 5:844-852.
39. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
40. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999, 11:4213-4225.
41. Marsicano G., Lutz B. Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 2006, 29:27-46.
42. Marsicano G., Wotjak C.T., Azad S., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
43. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behavior. Psychopharmacology 2002, 159:379-387.
44. McDonald A.J., Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 2001, 107:641-652.
45. Michaud J.L., Boucher F., Melnyk A., Gauthier F., Goshu E., Lévy E., Mitchell G.A., Himms-Hagen J., Fan C.M. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet 2001, 10:1465-1473.
46. Michaud J.L., Rosenquist T., May N.R., Fan C.M. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev 1998, 12:3264-3275.
47. Miczek K.A., Maxson S.C., Fish E.W., Faccidomo S. Aggressive behavioral phenotypes in mice. Behav Brain Res 2001, 125:167-181.
48. Miczek K.A., Yap J.J., Covington H.E. Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther 2008, 120:102-128.
49. Monory K., Massa F., Egertová M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J., Goebbels S., Nave K.A., During M., Klugmann M., Wölfel B., Dodt H.-U., Zieglgänsberger W., Wotjak C.T., Mackie K., Elphick M.R., Lutz B., Marsicano G. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51:455-466.
50. Pagotto U., Marsicano G., Cota D., Lutz B., Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006, 27:73-100.
51. Patel S., Hillard C.J. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 2008, 27:2821-2829.
52. Pecoraro N., Gomez F., Dallman M.F. Glucocorticoids dose-dependently remodel energy stores and amplify incentive relativity effects. Psychoneuroendocrinology 2005, 30:815-825.
53. Pecoraro N., Reyes F., Gomez F., Bhargava A., Dallman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004, 145:3754-3762.
54. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992, 106:274-285.
55. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
56. Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 2009, 12:1152-1158.
57. Ramos A., Berton O., Mormède P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 1997, 85:57-69.
58. Ramos A., Mormède P. Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 1998, 22:33-57.
59. Rodgers R.J., Johnson J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
60. Sewards T.V., Sewards M.A. Fear and power-dominance drive motivation: neural representations and pathways mediating sensory mnemonic inputs, and outputs to premotor structures. Neurosci Biobehav Rev 2002, 26:553-579.
61. Steiner M.A., Wotjak C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog Brain Res 2008, 170:397-432.
62. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983, 6:269-324.
63. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 1985, 9:203-222.
64. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology 1993, 111:323-331.
65. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53:865-871.
66. Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
67. Urigüen L., Pérez-Rial S., Ledent C., Palomo T., Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004, 46:966-973.
68. Viveros M.P., Marco E.M., File S.E. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 2005, 81:331-342.
69. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 2010, 30:11188-11196.
70. Wotjak C.T. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev Med Chem 2005, 5:559-570.